21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.

      Best Practice & Research. Clinical Gastroenterology
      Adult, Age Distribution, Aged, Aged, 80 and over, Biopsy, Needle, Carcinoid Tumor, classification, epidemiology, therapy, Combined Modality Therapy, Duodenal Neoplasms, Duodenoscopy, methods, Female, Humans, Immunohistochemistry, Incidence, Male, Middle Aged, Neoplasm Staging, Neuroendocrine Tumors, Prognosis, Risk Assessment, Sex Distribution, Somatostatinoma, Survival Analysis, United States, Zollinger-Ellison Syndrome

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Duodenal neuroendocrine tumors (NETs) comprise 2-3% of all GI endocrine tumors and are increasing in frequency. These include gastrinomas, somatostatinomas, nonfunctional NETs, gangliocytic paragangliomas, and poorly differentiated NE carcinomas. Although, the majority are nonfunctional, these tumors are a frequent cause of Zollinger-Ellison syndrome and can cause other clinical hormonal syndromes (carcinoid, Cushing's, etc.). In this chapter, their epidemiology, clinical aspects, localization, diagnosis and medical treatment are reviewed including the latest advances in each area.

          Related collections

          Author and article information

          Comments

          Comment on this article